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Executive Summary 
This report provides the key findings and recommendations of a study funded by the Economic and 
Social Research Council (ESRC) as part of a UK Research and Innovation (UKRI) Cross Council Initiative 
on ‘Tackling Antimicrobial Resistance (AMR)’. Our project is a Pump Priming study funded as part of 
Theme 4: ‘Tackling AMR beyond the Healthcare Setting’. The aim of the project is to address the 
responsibility of retailers in tackling the AMR challenge in the context of their chicken and pork 
supply chains, and to investigate this evolving role and how it might be shaped in the future, both in 
the UK and also extending to the global scale. This research is significant in light of the O’Neill (2016) 
report on Tackling Drug-Resistant Infections Globally, the Government Response to the Review of 
Antimicrobial Resistance (HM Government, 2016) and subsequent roles played by the Department 
for Environment, Food and Rural Affairs (DEFRA) and the Food Standards Agency (FSA) in taking 
forward their recommendations regarding the setting of targets for the reduction of antibiotic use, 
support for antimicrobial stewardship in the food system and the development of codes and 
standards for addressing AMR in the food system at both national and global levels. The O’Neill 
Report (2016: 29) calls for “producers, retailers and regulators to agree standards for ‘responsible 
use’. These standards could then be developed and implemented as an internationally recognised 
label, or used by existing certification bodies.” 
In food supply systems, as in human health, the focus of AMR policy has been on the use and 
stewardship of antibiotics in general, and Critically Important Antimicrobials (CIAs) in particular.  
Stewardship is significantly more complex than a reduction in antibiotic use and attention has been 
paid to stewardship related to good animal husbandry. Indeed, within the food industry antibiotic 
drugs remain important tools to support farm animal health and welfare, and the safety of foodstuffs.  
The research finds that AMR is being framed less as a food safety issue and more as a public health 
concern, cutting across multiple areas of policy and practice. Collaboration and pre-competitive 
agreements have been vital to the success of meeting antibiotic reduction targets in domestic 
production ahead of schedule. Next steps for food retailers and other actors in the food system include 
consideration of AMR beyond the sphere of domestic on-farm production of fresh food to tackle AMR 
as it presents in associated environmental reservoirs (water bodies, soils), in processed foods and 
through international food supply chains. 
Key Findings: 
 The greatest strides in the UK have been made in reducing antibiotic use in domestically 
produced, fresh meat. Meeting targets recommended by the O’Neill (2016) report, 
committed to by DEFRA and supported by the FSA, two years ahead of schedule without 
impacting on animal health, welfare or productivity is a significant achievement. 
 Central to the success of antimicrobial stewardship programmes in the poultry and pork 
sectors to date has been the treatment of AMR as a pre-competitive issue. Moreover, the 
collection and analysis of large datasets concerning on-farm antibiotic use and the execution 
of antimicrobial stewardship programmes have been managed effectively through food 
 “The rise of antimicrobial resistance is a global crisis, recognised as one of the greatest threats to 
health today … [T]his may even bring the end of modern medicine as we know it.  We need to act 
now to make sure this does not happen… Resistant pathogens travel very well internationally in 
people, animals and food… We should not blame any single sector. We are all in this together. We 
need ways to monitor progress and make quick course corrections if we are moving in the wrong 
direction. Antimicrobial resistance, as I say again and again, is a slow-motion tsunami. It is a global 
crisis that must be managed with the utmost urgency.” 
Dr Margaret Chan, Director General of the WHO, 18 April 2016 
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supply chain coordination, partnership and corporate responsibility, and via investment in 
training and infrastructure. 
 Consumers have limited knowledge of AMR. Consumers are also already overwhelmed by 
the volume of conflicting information they are bombarded with around food and health. 
 Whilst the monitoring and recording of antibiotic use in domestically-sourced fresh meat 
products to address the challenge of AMR is becoming more rigorous, robust and 
transparent, calculation by UK retailers and processors of AMR risk associated with imported 
and processed meat products is at a much earlier stage of development. 
 Environmental reservoirs, human-food pathways through handling foodstuffs and food 
animals (alive/dead) barely featured in discussion with the retail sector. 
 Combining publicly available trade and AMR risk data, the project demonstrates the 
potential use of maps in depicting AMR risk in international meat supply chains. The maps 
illustrate what might be achievable if granular data were available to industry practitioners. 
 
Key Recommendations: 
 Effective work has been conducted across food supply chains, including but not limited to 
Responsible Use of Medicines in Agriculture Alliance (RUMA), the British Poultry Council 
(BPC), the National Pig Association (NPA), Red Tractor and the Agriculture and Horticulture 
Development Board (AHDB), in rolling out platforms, guidance and training enabling data 
collection on antibiotic use. It would be useful going forward if the same platforms could be 
standardized to allow more research into any patterns that are emerging. 
 Data collection on antibiotic use needs to be comprehensive, collaborative, standardized 
and shared, whilst remaining pre-competitive. Companies should be able to use such data 
for their own benchmarking, and data can be anonymized and not made publicly available. 
 Dialogue is needed as the UK moves to a post-CAP (Common Agricultural Policy) landscape 
regarding priorities for farm investment in the context of AMR. 
 AMR raises important questions about public health, local practices and global connectivity, 
animal welfare, and household budgeting. At school level, AMR is potentially a productive 
lens to cut across disciplines such as geography and biology, but also food technology and 
citizenship classes in order to address public awareness through education. 
 Mapping AMR risk is likely to become particularly important, as the FSA highlights (Advisory 
Committee on the Microbiological Safety of Food, 2018), in the context of Brexit and should 
therefore be explored further. 
 Routes of AMR transmission beyond the food itself represent important areas for future 
attention. Pathogens resistant to antimicrobials, resistance genes and antimicrobial residues 
can travel and persist in soil, in water, and through direct contact with people including 
farmers, farm labourers, and abattoir workers. These routes require further research to 
inform evolving codes and standards for antimicrobial stewardship in food systems. 
 It is important for Codex Alimentarius Guidelines for Integrated Monitoring and Surveillance 
of Foodborne Antimicrobial Resistance, into which the FSA is crucially feeding, to address 
environmental reservoirs and internationally-sourced processed, as well as fresh, foods. 
These pathways are structured by the architectures of the global food system, coordinated 
in part by retailers and processors. 
 Scientific research on AMR in food should be conducted in collaboration with social scientific 
study of the organizational geographies of food supply chains. These global supply chains 
cross borders of national and regional regulatory systems. For antimicrobial stewardship to 
be implemented effectively, it is vital to grasp how responsibility is, and can be, practiced 
through border-crossing commercial realms.  
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1. Introduction 
This ESRC-funded scoping research, ‘Corporate food retailers, meat supply chains and the 
responsibilities of tackling antimicrobial resistance’, began on 1st February 2017, with the research 
element running from June 2017 to June 2018.  The project was jointly based in the School of 
Geography, Politics and Sociology at Newcastle University, and Geography and Environmental 
Sciences, Biological Sciences and the Business School of the University of Southampton.  It was 
supported by the Veterinary Medicines Directorate and by the Food Standards Agency as Project 
Partner. The research built on the proceedings of a 2016 workshop1 organized by the Universities of 
Southampton and Newcastle and the Food Standards Agency, and funded by the Network for 
Antimicrobial Resistance and Infection Prevention (NAMRIP), the Engineering and Physical Sciences 
Research Council (EPSRC), an ESRC Impact Acceleration Award and the Food Standards Agency. 
 
As the name suggests, AMR describes resistance developed by a microbe to the actions of an 
antimicrobial drug. Resistance to veterinary antibiotics is now widely acknowledged as having 
potentially catastrophic global implications, not only for animal and human health and wellbeing, but 
also for industrial sectors such as livestock agriculture and the wider economy.  In the last century we 
have come to rely on the effectiveness of antibiotics to manage and treat infection in people and in 
animals. It is commonly antibiotics that contain infectious diseases and enable the risks of routine 
surgery to be managed. In response to this threat there has been a raft of policy initiatives at 
international, national and food sector levels to drive forward initiatives to tackle AMR. Consequently, 
the stewardship of antimicrobials is complex; linear approaches are rarely, if ever, going to tackle it.  
 
The UK government has a stated desire to drive global policy leadership on AMR, with the 
commissioning of the O’Neill report in 2014, and its influence on EU and UN policy, seen as 
important elements of this. The O’Neill report (2016) focused on the potential economic implications 
of AMR and as such pushed AMR up the political agenda. AMR is often and rightly described as a 
‘wicked problem’.  Resistance is a dynamic process that appears to unfold differently in different 
situations. The UK 5-year AMR strategy engages a stewardship antibiosis model which focuses on 
knowledge and understanding of antibiotic resistance, with the stated aims of ensuring that existing 
treatments stay effective, and developing new treatments; responsibility for implementing its 
recommendations is spread across multiple Whitehall departments. Of most relevance to this 
project are the roles of the FSA and DEFRA, including the Veterinary Medicines Directorate (VMD). 
                                                          
1
 https://www.southampton.ac.uk/namrip/news/2016/12/joint-fsa-workshop.page (accessed 05/11/18) 
“AMR clearly involves biological processes, but the context which determines the operation of these 
biological mechanisms is shaped by social, cultural, political, and economic processes. The most 
effective actions to reduce and control AMR will involve changes in social practices, including how 
farmers, vets, and regulatory systems manage livestock production for human consumption; how 
regulatory and fiscal frameworks incentivise or deter antimicrobial development, production and use; 
and how public and healthcare professionals behave in relation to infection and use antimicrobials. 
The most critical feature of AMR is that resistance to a new antimicrobial begins as soon as it is 
developed, and so development of new antimicrobials is not a panacea. Providing a mechanism for 
sustainable use of the valuable resource of antimicrobials will therefore necessitate considerable 
behavioural, cultural, political and economic change throughout the world, which needs a strategy to 
be developed in harmony with the scientific and professional agenda” 
Anti-Microbial Resistance: Setting the Social Science Agenda  
Report of an ESRC Working Group: July 2014: 1 
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At the time of writing, only two years have passed since the 2016 O’Neill report identified the 
reduction of "the extensive and unnecessary use of antibiotics in agriculture" as one of four key 
interventions needed to tackle AMR.  To date, actors from across UK meat production, processing, 
assurance, retail and supply have been proactive in working together under the umbrella of RUMA to 
dramatically reduce the use of antibiotics generally, and Critically Important Antimicrobials (CIAs) 
specifically.  Indeed, the Veterinary Antimicrobial Resistance and Sales Surveillance (VARSS) report 
published in October 2017 detailed a 27% reduction in antibiotic use in livestock and fish farmed for 
food to an average of 45mg/kg, exceeding the government target of 50mg/kg two years ahead of 
schedule.2 This has been accomplished without compromising on animal health or welfare, or on the 
economic viability and competitiveness of the UK meat industry. This achievement should not be 
undersold. 
 
Antimicrobial stewardship refers not only to the act of reducing the usage of antibiotics, but also to a 
broader suite of practices that address animal health and welfare, and biosecurity, for example 
through on-farm infrastructure and production system improvements, selecting healthier breeds or 
strains and improved diagnostic techniques. However, given the complexity of AMR, and the ubiquity 
of microbes, the potential reach of antimicrobial stewardship extends beyond the farm gate to include 
improved hygiene routines in the food processing and packaging industries, and in the transit of 
animals and foodstuffs, as well as attention to how foodstuffs are kept, prepared and cooked in private 
and commercial kitchens. Stewardship is also about recognizing that all the techniques and tactics 
available may still fail to stop the emergence of resistance genes.  Antibiotic stewardship therefore 
must address not only the need to limit antimicrobial usage, but also to reduce the transmission of 
pathogens and of resistance, between microbes living in diverse environments.  Perhaps too, 
stewardship involves adaptation to a world where recovery times without antibiotic dosage may 
prolong illnesses in humans and animals.  
 
In order to deepen our understanding of the complex challenges outlined above, this scoping study 
explores the practices, concerns and responsibilities of retailers as they navigate international, national 
and trade body policies, the emerging science, and the on-the-ground practicalities of AMR. Pork and 
poultry supply chains were selected as they are examples of how organizations from across the 
industry have worked together to pioneer approaches to antimicrobial stewardship, through supply 
chains flowing through spaces of the global South as well as the UK and the global North.  Retailers are 
a key bridge between procedures of production and processing, and practices of consumption, so by 
looking across supply chains to unpack the role played by retailers, and the expectations placed 
upon them, it is possible to explore how the multiple actors from farm to fork negotiate and 
communicate to enact change. To this end, although we are interested in antibiotic stewardship and 
animal welfare, we are also keen to understand how other factors such as consumer expectations, 
the demands of local, national and international organizations, agencies and policies influence and 
interact with possibilities for change. 
  
                                                          
2
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/707974/_1274590-
v2-VARSS_2016_for_GOV.pdf (accessed 05/11/18) 
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2. Research Design 
2.1 Research purpose and background 
This study has been conducted with an ESRC Pump Priming grant, involving broad and exploratory 
goals. The project was a response to the 2016 UKRI Cross Council call for AMR research to address 
“the influence of large private sector organizations (e.g. supermarkets) on both consumer 
perceptions and farm practices, and how these can be utilised to positively infuence behaviour”3. 
Through gaining a more comprehensive understanding of the scope and scale of the AMR challenge 
in meat supply networks, we aim to offer insights of benefit to academics, industry and government, 
in collectively shaping approaches to tackling the risks of AMR. We explore how in real and emerging 
situations, organizations make sense of the uncertainty of the science of AMR whilst putting 
stewardship policies into practice. 
 
2.2 Research aims 
 To explore the evolving responsibilities of UK corporate food retailers in tackling AMR in   
their meat supply networks. 
 To facilitate increased dialogue and collaboration between food retailers and wider  
institutional policy and scientific networks in the UK in order to shape future strategy. 
 
2.3 Research objectives 
 To evaluate current and evolving corporate retail antibiotic stewardship strategies and  
standards in the UK. 
 To appraise the implementation of antibiotic stewardship policies across pork and chicken  
supply networks. 
 To unpack the influences of consumer expectations on approaches to tackling AMR. 
 To map the current AMR risks within UK chicken and pork retail supply chains. 
 
2.4 Project design and timeline 
This study built on the proceedings of a workshop organized by the Universities of Southampton and 
Newcastle and the Food Standards Agency on 25th November 2016.  Commencing in June 2017 the 
research combined desk-based research with in-depth interviews with a range of companies and 
organizations working within meat supply networks. The desk-based research included: i. a review of 
publicly available international, governmental and industry AMR policies and guidelines pertaining to 
pig and chicken meat supply networks; ii. a review of the social science AMR literature; iii. analysis of 
AMR coverage in the UK media; iv. experimental use of publicly available data to create dynamic 
maps within which UK retail purchases, UK supply networks, resistance figures for meat and 
carcasses in supplying countries (where available), and average antibiotic use in supply countries 
(where available) were plotted. 
  
The empirical research was conducted across two phases. In Phase One, we met with persons 
charged with developing, implementing and monitoring AMR policies for the major UK retailers. This 
included: a. interviews with nine of the UK top ten supermarkets. Within this we talked to seventeen 
people working as agricultural managers, technical directors, microbiologists, product safety and 
quality assurance directors and managers, and corporate responsibility and sustainability 
management; b. four interviews with nine people from eight industry bodies, including those tasked 
with developing, communicating or monitoring AMR related policies in practice; and c. consultations 
with seven staff from three policy-making bodies. In Phase Two, we extended our research across 
food networks and met meat processors, manufacturer representatives, farmers, trade bodies and 
others to further unpack how AMR emerges, is encountered, and is responded to at different nodes 
                                                          
3
 https://esrc.ukri.org/files/funding/funding-opportunities/amr/amr-theme-4-call-specification/ 
 
7 
 
in food networks. This included: d. thirteen interviews with farmers via the Farm Business Survey; e. 
three interviews with processors including representatives working across production, health and 
welfare, research and development, and technical; f. two telephone meetings with two of the trade 
bodies for manufacturers; and g. three other meetings, including with representatives of a 
consultancy firm working across meat supply chains, and a campaigning organization; h. five 
conferences attended at which we met and interacted with people working on AMR across human 
and animal health, in industry, in policy and in academia. The team has followed the ESRC’s 
Framework for Research Ethics and Research Data Policy throughout the project and the discussion 
and findings are presented without identifying any individuals or organizations participating in the 
research. 
 
2.5 Project academic team 
Professor Alex Hughes (Principal Investigator, Newcastle University) 
Dr Suzanne Hocknell (Post-Doctoral Research Associate, Newcastle University) 
Dr Emma Roe (Co-Investigator, University of Southampton) 
Professor Neil Wrigley (Co-Investigator, University of Southampton) 
Professor Michelle Lowe (Co-Investigator, University of Southampton) 
Professor Bill Keevil (Co-Investigator, University of Southampton) 
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We also thank the University of Southampton’s Frances Clarke in NAMRIP and Julia Branson, Gemma 
Gubbins and Andrew Sutton in the GeoData Unit for workshop support in 2016 and production of 
maps respectively, and Newcastle University’s Maddy Thompson, Adam O’Neill, Jane Tilbrook and 
Trudi Pemberton for 2018 workshop support. We are also greatly appreciative of the participation of 
all project interviewees in the research and of the contributions from speakers and delegates 
involved in the workshop on 19th November 2018.  
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3. Responsible Antimicrobial Stewardship: The Role of Collaboration 
3.1 Celebrating stewardship success 
There should be applause for the AMR stewardship approach that the UK food industry with support 
from the FSA has adopted in light of the UK Five Year Antimicrobial Resistance Strategy (DEFRA, 
2013) and the O’Neill (2016) report. The AMR stewardship approach adopted by the livestock, food 
retail and veterinary sectors has enabled antibiotic reduction targets to be surpassed two years 
ahead of schedule. This has been achieved in the UK through vets, drug manufacturers, assurance 
schemes, producers, retailers, processors and government coming together under the umbrella of 
RUMA to respond to key areas for action identified in the UK 5-year AMR Strategy 2013-2018. These 
were: optimizing prescribing practices; improving professional engagement, training and public 
engagement; and better access to and use of surveillance data when specifically applied to food and 
farming.  
 
Behind the headlines about reducing antibiotic usage there have been and continue to be ongoing 
activities to address more broadly the non-linear relation between the emergence and persistence 
of AMR. It is therefore particularly heartening to hear a UK trade body outline a more holistic, 
collaborative ‘One Health’ inspired stewardship plan: 
“Sector level responses have been very much qualitatively … thinking, ‘Well, what can we do 
in our industry? For example, to promote increased use of vaccination where possible, [or] 
preventative health measures, biosecurity on farm.’ So, it’s been an awful lot of renewed 
talk about prevention, about herd health plans on farms and things like that. So, people in 
the industry are looking at it in a much broader context. Yes, we know that the target is 50 
[mg/kg], but actually there’s much more qualitatively important topics to tackle here. So, 
we’re using that as an opportunity to have that renewed conversation … [T]he hard thing is 
to do on farms, to go back and rethink about, ‘Do I need to change my housing? Do I need to 
think about where I buy my stock from? Am I using the right vaccination regimes?’ And 
things like that”. 
Trade body respondent 
 
Effective antimicrobial stewardship is as much about co-creating the conditions for health, welfare 
and robustness under the ‘One Health’ agenda, as reducing total antimicrobial use.  
 
3.2 Supply chain collaboration on AMR stewardship 
In terms of effective implementation of antimicrobial stewardship, as the cornerstone of corporate 
strategy for tackling AMR, the structure and organization of meat supply chains are important. 
Project interviews reveal the critical role of supply chain collaboration and coordination in meeting 
targets within an antimicrobial stewardship model, and the experiences of this process as a non-
competitive issue. The collaborative industry body RUMA’s AMR strategy dovetails with the UK’s Five 
Year Antimicrobial Resistance Strategy (Department for Health and DEFRA, 2013) on this matter, by 
working to inform and influence best practice in the use and reduction of antimicrobials. These 
intentions have been embedded into supply chain auditing practices through the Red Tractor, a farm 
and food safety assurance scheme with very high membership in the UK livestock sector, which has 
incorporated standards for responsible use of antimicrobials from industry specific bodies such as 
the NPA and BPC. 
The top five retail firms—Tesco, Sainsbury’s, Asda, Morrisons and Aldi—hold just over 75% of the UK 
grocery market share at the time of writing.4 Likewise, in the case of the poultry processing sector, 
                                                          
4
 https://www.kantarworldpanel.com/en/grocery-market-share/great-britain (accessed 23/08/18) 
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only four companies, some of them multi-national, control around 90% of the UK market.5 Key 
points emerging from interviews on the implementation of antimicrobial stewardship in pork and 
poultry supply chains are: 
 Large sets of data on antibiotic use in both poultry and pork production for fresh and 
domestically-sourced product are increasingly held by supermarket chains and processors. In 
some cases, specialist consultancy firms are involved in this data collection and analysis. Some 
interviewees reflect on the potential of blockchain and radio-frequency identification (RFID) 
technologies to hold data pertaining to aspects of AMR. 
 The management and monitoring of antibiotic use is effectively handled, for the most part, by a 
relatively small number of players across the consolidated grocery retail, poultry and pork 
sectors (pork to a lesser extent than poultry). This consolidation can generate economies of scale 
and efficiencies in data collection and handling, stewardship collaboration with fewer vet 
companies and less yet more valued communication channels between industry and policy-
makers. 
 Effective antimicrobial stewardship is achieved through stability in the supply chain in terms of 
the length of contracts retailers have with suppliers, along with the closeness of buyer-supplier 
relationships in some cases and supply chain integration in a minority of others. Longer term 
contracts with suppliers are suggested by some interviewees to be helpful in managing data 
collection concerning antibiotic use, in ensuring that best practice and standards of antimicrobial 
stewardship are developed and implemented, and also as potentially giving the financial security 
necessary to invest e.g. in housing. Some interviewees reflect that AMR collaboration is eased by 
histories of retailer-supplier relationships emphasizing cooperative, developmental processes 
rather than setting targets in more punitive terms. 
 Strong organizational structures of corporate responsibility have aided the effective 
implementation of wider programmes of responsibility in agricultural production, including farm 
animal welfare, and health and safety, into which stewardship fits. 
 Investment in hard (new buildings, equipment) and soft (training and data collection) 
infrastructure to support AMR stewardship plans has been easier for larger suppliers and farms 
who tended to be in a stronger position to invest. Funding constraints and insecurity of contract 
have implications for small and medium-sized farms and firms, which require further research. 
 
3.3 The importance of pre-competitive agreements 
Key to the success of stewardship is the agreement, reflected by our study’s interviewees, that the 
issue of AMR is pre-competitive:  
 
 “Poultry is a prime example of how it should be an industry driven approach. It’s, ‘This is 
what we are going to do. This is the advice. These are the reasons why we are going to do 
it’… It’s very important that this becomes industry driven, not retailer driven”. 
 Retail respondent 
 
Achievement in antimicrobial stewardship should not be undersold. It has required significant 
industry-wide collaboration. This was not a race to be first. Rather, the industry responded to the 
AMR challenge by collaborating through knowledge exchange and the sharing of best practice. This 
marked a broad and inclusive sign-up to the AMR stewardship agenda, something retailers feel could 
be at risk if the coordination of initiatives is moved towards encouraging market competition, rather 
than cross-industry collaboration. 
 
                                                          
5
 https://www.foodnavigator.com/Article/2017/09/26/Consolidation-in-UK-poultry-as-Cargill-Faccenda-form-JV (accessed 
23/08/18) 
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The antimicrobial stewardship achievements from the UK food and farming industry and policy 
makers are unusual not only in terms of the speed, depth and method of precautionary 
collaboration, but that this has largely happened below the radar of consumers:   
 “I am not aware we have had any direct contact on it [from consumers]. If a letter goes to 
our Chief Executive it will come to the relevant person in the business to deal with and I 
don’t recall ever seeing a letter into [our company] about [antimicrobial] resistance”. 
 Retailer respondent 
 
Retailers are deeply concerned that overly simplistic reporting of this complex issue may result in 
consumer demand for antibiotic-free labelling with attendant negative impacts on the existing pre-
competitive collaboration.  Successful antibiotic stewardship on farm involves the interplay of 
prescription practices, HACCP (Hazard Analysis and Critical Control Points) plans, biosecurity 
procedures, welfare standards, staff training and more, so such a two-tier system is unlikely to hold 
any overall benefits for antibiotic use if animal welfare is to be maintained. 
 
The achievements of the pig and poultry sectors in reaching the recent antibiotic reduction targets 
point to the opportunities available to avoid the prescription of antibiotics when the welfare of 
animals was not affected. At a farm level, this collaboration has been underpinned, as outlined 
earlier, by industry bodies (such as Red Tractor, the BPC and the NPA) who have facilitated 
communication, data collection, auditing and training within and across the different sectors. 
Meeting the national targets without adversely impacting on animal health and welfare has included 
agreements on a reduction in the use of antibiotic antimicrobials aided by targeted increased use of 
vaccination and diagnostics, alongside herd health plans and ongoing improvements in knowledge 
and practices of hygiene, biosecurity measures, and welfare arrangements. Collaborative 
agreements are key to minimizing the cost and time burdens on farmers:  
 
 “[Retailers] are harmonizing [the] on-farm practices [of their suppliers], so they’re [creating] 
requirements for farmers as well. I think [it] is quite important that farmers are getting the 
same messages. Because at the end of the day there is a scientific way to address this. So for 
farmers to get that similar message, regardless of who they’re selling their produce to, I 
think is really important as well, in terms of them understanding that. Yes, we all know what 
we’re talking about and we all understand what responsible use looks like, and it should be 
the same language”. 
 Trade Body Respondent 
  
On farm, the relatively few antibiotics registered for use in many species is an added complexity that 
serves to illustrate that ultimately stewardship success lies in the practices of livestock farming. 
Stewardship involves understanding the health and welfare needs of animals in the context of the 
reduction targets, and our interviewees highlighted the role of data collection and analysis here. 
 
3.4 AMR as a public health issue 
The targets for antibiotic use arguably arose from conceiving a relatively straightforward relationship 
between antibiotic use and the incidence of resistance. However, scientists increasingly understand 
that the pathways of microbial resistance are complex and non-linear. Science still holds that the 
more often an antibiotic is used the greater the risk of the emergence of antibiotic resistance in the 
future. However, it is becoming clear that point of use is not the only risk. As such, the precautionary 
antimicrobial stewardship policies and practices of the industry have to some extent been ahead of 
the scientific evidencing of the mechanisms involved in AMR emergence and transmission.  
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Antimicrobial resistance does not simply fall under the umbrella of a food safety issue. As outlined 
above, antimicrobial resistance is a ‘wicked problem’, multiple in location, encompassing the 
movements of wild, farmed and companion animals and humans, the organisms within soils or 
water bodies, plants and fungi. As one retail respondent put it:  
 
 “This is not a linear food safety risk but a broader public health issue, the linkages of which 
are not very understood”. 
 Retailer respondent 
 
Antimicrobial resistance is a direct concern for the food industry because it places at risk the 
effectiveness of the use of antibiotics on animals and may lead to changes in production costs and 
systems. Yet the food industry, as well as producing food, is entangled with the emerging public 
health crisis through local and global pathways that connect microbes. The handling of animals living 
or dead, and their excretions, may facilitate the transfer of microbes with resistance genes.  Animal 
health, human health and the environment are connected in multiple ways including through the gut 
flora of stomachs, human and animal. The urge to harmonize data collection under the ‘One Health’ 
agenda across the food, animal health and human health industries potentially has a key role to play.   
 
3.5 Consolidating data 
Food industry players have traditionally held trade and supply chain production data close to their 
chest, preferring not to share something potentially commercially sensitive. Some parts of the 
industry are benchmarking the average total use of antibiotics of their supply chains alongside other 
data. Such benchmarking sits behind the publicly available data detailing achievements in meeting 
the average use antibiotic targets. In order to keep the management and response to AMR pre-
competitive, the benchmarking continuum is only accessible to those within the system.  A question 
arises here as to how collaboratively to use this data to better understand the challenges of different 
farming situations and so to share best practices across diagnosis, housing, feed, hygiene, genetics 
and more, as well as supporting scientific study into resistance:  
 
 “The ideal would obviously be a health and welfare platform. The farmers can see all their 
data, all at once and analyze it and it can produce graphs and things.  I think, as well, the 
hope is that CCIR6 data, the carcass conditions at the slaughterhouse… all different health 
conditions that are spotted and recorded at the slaughterhouse, that data is supposed to be 
fed back to all the farms and it currently isn’t [fed back to the farms] very well. It will be a 
really useful resource for farmers to use for overall health and welfare [management], but 
it’s definitely something that’s not going to happen overnight”.  
 Industry body respondent 
 
Looking beyond the farm gate, questions are also circulating about how to maximize the utility of 
wider supply chain surveillance and due diligence practices to tackle and better understand AMR as 
a dynamic phenomenon. The commercial interests of the food industry stand in relation to 
international and national public body moves to govern the issue. Overcoming the AMR challenge 
cannot become an industry competitive issue and it cannot be something the UK, or Europe, does by 
itself. There needs to be continued acceptance across human and animal health, and the whole food 
system that microbes know no borders. The complex issue of AMR cannot be tackled by legislation 
alone. Collaboration across the board is key to meaningful stewardship. 
  
                                                          
6
 Collection and communication of inspection results. https://pork.ahdb.org.uk/processing/collection-and-communication-
of-inspection-results-ccir/ (Accessed 05/11/18) 
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4. Complex Risks of AMR in the Food System and the Challenges of Consumer and Policy 
Engagement 
4.1 Living with microbial Life 
To understand the shape and form of UK and international policy on AMR, and to situate the 
aforementioned antimicrobial stewardship programmes, it is helpful to place policy in the context of 
how science and society has framed both microbes and AMR. This framing has implications for how 
communities grapple with the challenges of disease prevention and management and drug 
resistance, and gives context to the fresh challenges highlighted in the next sections of this report. 
 
‘Microbes’ refers to a diverse group of organisms too small to be seen without a microscope, 
although many of them are visible to the naked eye when clustered together in communities.  
Typically, microbes reproduce through asexual reproduction.7 Microbe evolution is therefore not a 
matter of two organisms mixing their genes by way of sexual reproduction.  However, neither is it 
solely as a result of mutation. Microbes have access to the genetic ‘data bank’ known as the 
pangenome. Microbes can use a process called lateral gene transfer (LGT) to pick up and try on for 
size genes from other microbial organisms within the pangenome. If a gene that a microbe accesses 
and tries is more useful than detrimental, it can then spread rapidly through microbial reproduction. 
Here the local material contingencies shape the usefulness of the gene. The processes of LGT, even 
without selection for resistance to antimicrobial drugs, continue to drive individual and collective 
microbial evolution in the pangenome. Attention to singular microbes is therefore insufficient to 
grasp what microbes are, or what they can do.   
 
Historically, the scientific study of microbes has involved isolating a microbial organism from wider 
communities. For philosopher of science Dupré, this goes some way to explaining why microbial life 
has often been understood as simple and behaviourally limited, whereas they are “in fact, the 
evolutionary sophisticates” (2012: page 171). Microbial life can be thought of as a collective.  That 
collective is simultaneously a collective of individual organisms that in any given situation may be 
competing, collaborating or indifferent to each other, and the pangenome which includes the total 
collection of the genetic information of all those individuals. Microbial communities played key roles 
in the geochemical development of the planet and its atmosphere. Microbes make their homes in 
soil, in water, in and on other life forms, and they are an integral part of the bodies of multi-celled 
organisms, including humans. For Dupré, microbial organisms carry out “essential metabolic 
processes that we, in the narrow single-organism or single-genome sense, have never evolved for 
ourselves” (2012: page 165). Dupré goes on to suggest that relationships with microbes may be at 
least as important for health as for disease. 
 
4.2 The emergence and persistence of antimicrobial resistance 
Antimicrobial pharmaceuticals were first developed just over 100 years ago and work by upsetting 
structures or processes that exist in microbial, but not eukaryotic cells. What is significant here, 
though, is that they were developed from substances that are themselves produced by microbes. 
This suggests that the term antimicrobial is perhaps something of a misnomer.  As explored above, 
what we call drug resistance was part of the evolutionary strategies of microbes long before the 
pharmaceutical industry became involved. However, what has changed is that the use of 
antimicrobial drugs has increased the rates of gene transfer in organisms of most concern to human 
and animal health, and relatedly, livestock productivity.   
 
AMR is a product of lively interactions involving living organisms within dynamic ecologies. This 
suggests that so called antimicrobial drugs are not, and have never been, magic bullets on a singular 
trajectory to cleanly take out pathogenic microbes. Studies in Sweden suggest that decreasing 
                                                          
7
 ‘On average, under ideal conditions, bacteria may double in number every 20 minutes.’ In 7 hours one can become over 2 
million. http://www.fao.org/3/a-i5896e.pdf (accessed 05/11/18). 
13 
 
antibiotic use does not necessarily lead to a reduction in AMR associated with a particular drug (at 
least in the short term) (Kahn, 2016: page 82). The ability of microbes to adapt to antimicrobial drugs 
means that neither better prescribing, nor the development of new drugs will be sufficient to stop the 
spread of AMR. Indeed, commensal (harmless) bacteria can host antimicrobial resistance genes from 
which pathogenic bacteria can draw, including genes that may be resistant to antimicrobials other 
than the one that the microbe has been exposed to. Antimicrobial drugs remain an important 
strategy to take out a direct disease threat in the now, but whenever they are used they add fuel to 
the fire of future resistance. 
 
4.3 Consumers 
One of the steps recommended by the O’Neill report was for: “Food producers and retailers to … 
improve transparency for consumers regarding the use of antibiotics in the meat that we eat, to 
enable better informed decision-making by customers.” (2016: page 73). Project interviews confirm 
that public knowledge and understanding of AMR is very limited and is represented neither as a 
significant consumer concern in customer research, nor through customer correspondence. More 
specifically, for example, there is limited grasp on the part of consumers of antibiotic use in farm 
animal production and effects of antibiotic withdrawal periods. Retail interviewees reflect on 
customer research revealing care for issues of provenance and animal welfare, though with product 
quality and price unsurprisingly foregrounded. So, whilst retailers themselves may have an 
incomplete knowledge, their experience of food consumers in general is that their understanding of 
the topic is even more limited. 
 
Consumer anxiety about antibiotic consumption through residues in food products is not really the 
AMR challenge that the industry faces. Nevertheless, this consumer concern has sparked the use of 
the only AMR related marketing slogan “Antibiotic Free”. Our respondents felt that such labelling 
gives out unhelpful messages, adding to consumer misunderstandings about residues in meat, whilst 
threatening both animal welfare and pre-competitive commitments on AMR. They were also 
concerned that consumers do not fully understand the labelling that already exists, and were keen 
to stress that consumers are overwhelmed by information about food. In the light of this, our retail 
respondents saw it as their duty to do the right thing from the outset rather than wait for consumer 
concerns to emerge.  
 
Whether responses to AMR per se (as opposed to antibiotic-free) can ever feature as a marketing 
quality is a different question. Some respondents spoke of the marketing point of difference for 
those with strong farmer relations where they could sell responsible antibiotic use as part and parcel 
both of high-welfare and of ensuring a good procurement system. Others realized that it is not 
appropriate to have a point of competitive difference if it is realized as a fundamental food safety 
issue. And ultimately without a more informed consumer, active marketing on the topic is ambitious. 
It is unknown how it may become a food scare that would drive changes in consumer buying habits; 
food retailers historically are differently affected by food scares related to their brand image. 
 
4.4 Policy 
The sector is commercially sensitive to negative public exposure about their brands, which has often 
been the stick used by regulatory bodies to drive faster improvements. Independently of consumer 
ignorance on the topic of AMR, negative brand publicity is unwanted by the sector, and where there 
have been easy wins through industry cooperation e.g. reducing campylobacter in poultry, the 
industry is keen to collaborate pre-competitively. Therefore, significant thought is warranted about 
how cooperation across the industry to address the topic of AMR as more complex than antibiotic 
stewardship can be driven forward.  
 
14 
 
Retailers reacted with some concern that they were being positioned as having great influence over 
AMR in the supply chain, when it is recognized that some reservoirs fall outside of the borders of the 
farm or the product: 
 
“I don’t like AMR as a target, because I can’t manage it … there might be a microbe evolving 
with antibiotic resistance in the canal as we speak. What I can be responsible for and 
influence is antibiotic use, which may indirectly lead to antibiotic resistance, but I have no 
control of antibiotic resistance.”  
Retailer respondent 
Antibiotic usage is where food sector policies on AMR are commonly positioned. This includes both 
total use and minimizing the use of Critically Important Antibiotics (CIAs), although in reality it was 
pointed out that what is on these lists is inconsistent nationally, internationally and by corporation, 
which is unhelpful.  
 
Antibiotic use is still acceptable, indeed necessary, but it is part of a complex conversation with 
consumers around reducing usage, and how this relates to animal welfare across different 
production systems. A recent POST (2018) publication details the extensive work to address AMR by 
reducing antibiotic usage through a number of improvements to husbandry, breed selection on 
health, diagnostic testing, and more. This therefore begs the question of a conversation with 
consumers within the ‘less but better meat’ framework about the environmental, welfare and health 
costs of different methods of livestock production. That is not to suggest that AMR is a topic suitable 
to sit under the umbrella of ‘ethical consumerism’, nor is it a food safety concern. Rather, it is an 
environmental problem with potentially serious public health implications in future decades. 
Investment in tackling AMR will not be found through profit margins in a competitive market for 
‘healthier’ foodstuff, as the pathways of the movement of resistance genes between the potential 
reservoirs are too entangled to delineate supply chains and products in this way.  
 
The ‘One Health’ paradigm is very pertinent to explain and inform policy-making around AMR, yet to 
date the scientific and public health culture has limited the apprehension of the AMR challenge by 
not earlier recognizing the porosity of borders between human, animal and environment and its 
many and varied inhabitants. Where historically concern for livestock production practices has 
driven a market in ‘higher animal welfare’ or ‘more extensive’ farming systems, it is hard to see how 
AMR taps into what one can now be appreciated as a siloed approach to a singular, rather than 
ecological, challenge, across the supply chain.  AMR is a risk in the environment, but as the retailer 
reflected above, environmental reservoirs of resistance genes may feel beyond their scope. Our 
research indicates that there is space to explore how one might innovate products and markets that 
directly tap into the ecological relations of the ‘One Health’ agenda and that might deliver 
consumer-facing messages on the topic. 
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5. New Horizons and the Mapping and Tackling of AMR Risk in Food Systems 
5.1 The significance of maintaining inter-firm collaboration and support from stakeholders 
Collaboration has been a crucial part of addressing the challenge of AMR and in the achievements so 
far. The O’Neill (2016) report has been welcomed, and the discursive space of RUMA has been found 
to be useful, as have the resources produced. There is occasional confusion regarding the complexity 
of different lists and policies concerning CIAs, as well as concern that to restrict more classes of 
antimicrobials could threaten pre-competitive agreements and animal welfare without necessarily 
impacting on stewardship in any meaningful way.  AMR is generally viewed as a pre-competitive 
issue, and therefore organizations such as the British Retail Consortium (BRC) Antibiotic Working 
Group are important for supermarket chains to address ongoing challenges in collaborative ways, 
involving their agricultural managers, product technologists and corporate microbiologists.  
Many companies, recognizing the complexity of the AMR challenge, express a need for more advice, 
clarity and direction when it comes to managing AMR risk in their supply chains most effectively.  
There is also broad acknowledgement that more research is needed to understand the persistence 
of AMR. Specialist consultancy firms have a continuing role to play in terms of services and training 
for antimicrobial stewardship and data collection. There is also scope for collaboration beyond the 
farm between different sectors of the food industry. As many of our project interviewees rightly 
point out, AMR is a challenge requiring coordinated policy response, data collection and surveillance 
across industries, from grocery retail and food processing sectors to the hospitality industry and 
public sector food production and provisioning across international supply chains. 
5.2 The possibilities of mapping AMR risk in international supply chains 
Whilst the monitoring and recording of antibiotic use in domestically-sourced fresh meat products to 
address the challenge of AMR is becoming more rigorous, robust and transparent, calculation by UK 
retailers and processors of AMR risk associated with imported and processed meat products is at a 
much earlier stage of development. And yet, the international supply, in particular of processed 
meats, is significant. Raising awareness and developing responses to address the incidence of AMR 
in domestic and international food chains has been slow, with public health officials only just starting 
to engage with this economically and politically charged arena (George, 2018). As in human clinical 
settings, across the food sector we see the replication of ‘dealing with AMR’ through reduction in 
point of prescription usage, as opposed to infection prevention through improved biosecurity across 
the complex geographies of reservoirs where resistance genes could flourish in the agri-food supply 
network. As the Food Standards Agency’s Advisory Committee on the Microbiological Safety of Food 
(ACMSF) fixed-term task and finish group’s report on antimicrobial resistance published in March 
2018 highlights: 
“[T]here is significant and longstanding lack of antimicrobial and AMR data in relation to UK-
produced, processed and/or imported food, in absolute and comparative terms … Apart from 
a small number of northern European countries… there is little or no data on AMR in foods 
imported into the UK. Brexit-related changes in the relative amounts of foods imported from 
non-EU countries are likely to change the qualitative and quantitative antimicrobial and AMR 
related challenges”  
ACMSF 2018: Pages 12-13 
 
The project team combined trade data from the Agricultural & Horticultural Development Board 
with publicly available data on test results for the presence of antimicrobial factors, mainly from the 
European Food Safety Authority, in order to illustrate what retailers and other companies could do 
with their own and/or shared corporate data to support the management of AMR risk in their 
international as well as domestic supply chains. It is possible to visualize risks of AMR presence at 
different nodes in food supply chains through mapping exercises. The maps in Figures 1 and 2 are 
experimental in this respect and have been produced by the University of Southampton’s Geodata 
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Institute.8 They depict the risk of the presence of Campylobacter coli resistant to Ciprofloxacin, in 
fresh and processed poultry meat respectively, imported into the UK. Figure 2 is important in 
showing Thailand as a significant supplier of processed poultry meat to the UK; a supply chain 
important for its connection to UK retailers’ store networks in South East Asia that can provide a 
boost to the agri-food exports of emerging markets. However, there is limited attention as yet paid 
to these international supply chains in terms of their role as global pathways of AMR. The publicly 
available data shows country of origin testing of carcasses and meat, not who and what such 
products (or the animals they were made from) come into contact with as they move through supply 
chains. A further limitation in producing these maps was the incompatibility of international datasets 
on antibiotic use in animals. 
 
Although the data to which we had access have limitations and can mask particular trade 
complexities such as continental meats being labelled in their processing country, it demonstrates 
what kinds of mapping exercises for risk management could be conducted by retailers and other 
companies through sharing of more fine-grained data in the future. This is likely to become 
particularly important, as the FSA highlights, in the context of Brexit. In October 2018, the European 
Parliament voted in favour of tighter regulation concerning on-farm antibiotic use, extending to non-
EU suppliers in several years’ time. 9 There is a UN policy on a phased rolling out of AMR national 
plans, including support in doing this for the global South, but little of this has been conducted in the 
farming sector outside of Northern Europe (and even that data is sparse and incompatible). 
 
Figure 1 
 
                                                          
8
 2012 was the year for which most complete trade and AMR risk data was available using these particular datasets 
9
 http://www.europarl.europa.eu/news/en/headlines/society/20181018STO16580/veterinary-medicines-fighting-
antibiotic-resistance (accessed 09/11/18). 
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Figure 2 
 
 
5.3 Tackling AMR beyond the management and monitoring of antibiotic use: Environmental 
vectors of AMR transmission beyond the farm 
What type of response from the food sector, including retailers, is required beyond reducing 
antibiotic usage in supply chains? And where should it be targeted along complex international food 
supply networks and with so many potential reservoirs for resistance to flourish? Most commonly 
only one of the eight potential areas of AMR reservoirs (ACMSF: 2018) was routinely identified by 
interviewees – that is food producing animals, in other words taking the clinical setting of concern 
for humans and translating it to animals, which is ultimately what the antibiotic stewardship targets 
address. The other environmental reservoirs, human-food pathways through handling foodstuffs 
and food animals (alive/dead) barely featured in discussion with the retail sector. This is perhaps not 
surprising when the scientific evidence about these potential pathways of transmission is patchy and 
communication about these sites as carrying risk has to date been poor. However, alongside the new 
horizons for addressing AMR presented by international meat supply chains and global pathways of 
AMR linked to processed as well as fresh meat, routes of AMR transmission beyond the food itself 
represent important areas for future attention. Eating properly cooked meat carries a negligible 
AMR risk. However, pathogens resistant to antimicrobials, resistance genes and antimicrobial 
residues can travel and persist in soil, in water, and through direct contact of people including 
farmers, farm labourers, and abattoir workers with AMR carrying microbes in the environment. As 
UNEP explains, “antimicrobial concentrations in most effluents are too low to be lethal to exposed 
bacteria, but may be sufficient to induce antimicrobial resistance” (2017: page 15).  Strategies and 
standards for addressing AMR therefore need to consider these vectors alongside continued 
programmes of work reducing farm-level antibiotic use. Moreover, these vectors also operate on a 
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global as well as local and national scale. There is therefore a challenge ahead in terms of addressing 
the flows of AMR in the context of what Figure 3 shows as key transformations in the food system, 
including not only upstream segments in a domestic context, where antimicrobial stewardship is 
currently focused, but also a wider set of AMR transmission vectors throughout the food system, 
including the ‘hidden middle’ and accompanying environmental reservoirs.  In the Government 
Response to the Review on Antimicrobial Resistance (HM Government, 2016: page 16), “Codex 
Alimentarius (the joint FAO/WHO body dealing with food) … agreed to establish an 
intergovernmental task force on antimicrobial resistance in 2017”. A key objective of Codex at the 
time of writing is to develop “the draft Guidelines for Integrated monitoring and surveillance of 
foodborne antimicrobial resistance”.10 It is important for these guidelines to incorporate pathways 
of AMR relating to environmental reservoirs and associated with the architectures of the global food 
system, which are in part coordinated by retailers and processors. 
 
Figure 3 
 
 
  
                                                          
10
 http://www.fao.org/fao-who-codexalimentarius/news-and-events/news-details/en/c/1161586/ (accessed 09/11/18). 
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6. Findings and Recommendations 
The presence of antimicrobials has changed the rates of transmission of genes that are detrimental 
to the health of humans and animals and to food security. Antimicrobials may not be magic-bullets. 
They are, however, for now at least, important tools in aiding recovery from pathogenic disease. Yet, 
the abilities of microbes to adapt to antimicrobial drugs mean that neither better prescribing, nor the 
development of new drugs will be sufficient to stop the spread of AMR. Across the food industry the 
key, widely-accepted messages are that a. any use of antimicrobials carries with it the risk of the 
development of resistance to that (and other) antimicrobials; b. antimicrobials should be used 
judiciously to reduce the frequency of the occurrence of resistance; c. the risk of resistance 
developing will never be reduced to zero.  
 
The emergence and resilience of AMR is not a product of a linear cause and effect relationship. In 
the UK, cross-industry collaboration has been central to the production of accessible, bite-sized 
information and practical advice that has enabled significant strides to be made in understanding 
and antibiotic reduction targets to be met ahead of schedule. Retailers’ pre-competitive agreements 
have been a key element of the success of these collaborations. Such agreements have aided a more 
holistic stewardship approach, which thinks ecologically about health, welfare, biosecurity, training 
and so on rather than being focused solely on antibiotic reduction. Such agreements have also aided 
an open conversation about both the limited AMR gains and the risks to health and welfare 
entangled with the use of antibiotic-free labeling. 
  
6.1 Stewardship and collaboration 
Findings: 
 The greatest strides in the UK have been made in reducing antibiotic use in domestically 
produced, fresh meat. Meeting targets recommended by the O’Neill (2016) report, 
committed to by DEFRA and supported by the FSA, two years ahead of schedule without 
impacting on health, welfare or productivity is a significant achievement. The VARSS report 
published in October 2017 detailed a 27% reduction in antibiotic use in livestock and fish 
farmed for food to an average of 45mg/kg, exceeding the government target of 50mg/kg two 
years ahead of schedule. Stewardship involves understanding the health and welfare needs 
of animals in the context of the reduction targets, and our interviewees highlighted the role 
of data collection and analysis. Also, we note here the importance of integrated disease 
management plans. Integrated approaches can have significant impacts on reducing disease 
incidence and control of antimicrobial usage. 
 Central to the success of antimicrobial stewardship programmes in the poultry and pork 
sectors to date have been the treatment of AMR as a pre-competitive issue and the efficient 
collection and analysis of large datasets concerning on-farm antibiotic use, managed most 
effectively in food supply chains through stability, partnership, corporate responsibility 
and investment in training and infrastructure. 
 The collaborative approach of the UK industry has allowed training materials to be 
developed for staff within some sectors. However, as discussed above, AMR is a complex 
issue and across the industry understanding of the technicalities of AMR is variable. 
 
Recommendations 
 Effective work has been conducted across food supply chains, including but not limited to 
RUMA, BPC, NPA, Red Tractor and the AHDB in rolling out platforms, guidance and training 
that enabled data collection on antibiotic use. The publicly available figures for antibiotic 
use are averages over the year. This is important, as different farms have different 
challenges at different times.  Disease outbreaks happen in all species, and farmers should 
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not be penalized for caring about the health and welfare of their animals. However, it would 
be useful going forward if the same platforms could be standardized to allow research into 
any patterns that are emerging. 
 To understand more about the emergence of disease, and so the need for treatment with 
antimicrobials, data collection needs to be comprehensive, collaborative, standardized and 
shared, whilst remaining pre-competitive. Companies should be able to use such data for 
their own benchmarking, and the data can be anonymized and does not need to be publicly 
available. Such datasets should be available for scientific analysis into patterns of disease, as 
they relate to such things as weather, feed, stockperson skill, housing type and strain, with a 
view to producing recommendations for improving on health and productivity outcomes 
generally, as well as antimicrobial use specifically. What is key is that such data collection is 
the collective responsibility of the food chain as a whole. This raises key questions for the 
industry and policy makers to explore around financing such a system, and of ease of use on 
the ground. There are opportunities here for UK policies and companies to be world leading 
in their collaboration and holistic approach to AMR. The UK is already well placed to do this, 
for example by building on the electronic Medicine Book (eMB) system that has rapidly been 
rolled out across 90% of the pig industry.  
 Dialogue is needed as the UK moves to a post-CAP landscape regarding priorities for farm 
investment in the context of AMR. The stewardship approach already situates AMR within 
animal health and welfare policy and practices. As such, there is potential for including 
consideration of future investment, e.g. in improved housing stock, within the lens of AMR 
oriented policies and practices. Related to this is discussion around small and medium sized 
farms. Our research had pig and poultry supply chains as its focus. These industries have 
been fast moving on AMR, in no small part aided by the consolidated and coordinated 
nature of these industries enabling training and investment within their systems. Attention 
needs to be paid to the risks of passing the burdens of implementing change down the 
chain on to farmers, and in so doing further squeezing small players who are forced to 
absorb such costs, often without security of contract. 
 Our research suggests it could be useful to supplement sector specific training with a 
knowledge based industry-wide training (similar in structure to the basic food hygiene 
certificate) that sits before the sector specific training and situates AMR as a public health 
issue in an ecological context. This could include the food hospitality and public sectors, as 
well as food retail and production. 
 
6.2 Consumer engagement 
Findings: 
 Consumers have limited knowledge of AMR. Consumers are already overwhelmed by the 
volume of conflicting information they are bombarded with around food, health and eating. 
The ‘less but better meat’ campaign is potentially valuable here, but it is also a sensitive 
subject as food choices are deeply entangled with abilities to pay. There have been 
campaigns aimed at encouraging consumers to eat a wider range of cuts of meat, but so far 
with limited success. 
 
Recommendations 
 More research is needed on public engagement with AMR, as knowledge is not sufficient to 
change behavior, given that food practices are mundane, habitual and embedded in familial 
and community routines. 
 AMR raises important questions about public health, local practices and global connectivity, 
animal welfare, and household budgeting. At school level AMR is potentially a productive 
lens to cut across disciplines such as geography and biology, but also food technology and 
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citizenship classes. Many of our research participants raised the issue of consumer 
disconnect from food production. Initiatives such as Open Farm Sunday were seen as 
important here and there is potential to explore this further. 
 
6.3 New Horizons 
Findings: 
 Whilst the monitoring and recording of antibiotic use in domestically-sourced fresh meat 
products to address the challenge of AMR is becoming more rigorous, robust and 
transparent, calculation by UK retailers and processors of AMR risk associated with 
imported and processed meat products is at a much earlier stage of development. 
 Environmental reservoirs, human-food pathways through handling foodstuffs and food 
animals (alive/dead) barely featured in discussion with the retail sector. 
 The mapping element of this research raised some significant issues with regard to 
understanding AMR in the context of public health and food systems. The maps begin to 
demonstrate what might be achievable if granular data are available to researchers and 
industry practitioners. 
 
Recommendations 
 Mapping AMR risk is likely to become particularly important, as the FSA highlights (Advisory 
Committee on the Microbiological Safety of Food, 2018), in the context of Brexit and should 
therefore be explored further. The European Parliament has recently moved to strengthen 
EU legislation on agricultural antibiotic use. If this legislation is adopted by the Council key 
changes include limiting prophylactic use to individual animals, and empowering the 
European Commission to reserve CIAs for human use.11 If the UK post-Brexit moves to 
import less meat from the EU, which is globally leading on tackling AMR, there may be 
shifting risks that require research and strategic response. 
 Alongside the new horizons for addressing AMR presented by international meat supply 
chains and global pathways of AMR linked to processed as well as fresh meat, routes of AMR 
transmission beyond the food itself represent important areas for future attention. 
Pathogens resistant to antimicrobials, resistance genes and antimicrobial residues can travel 
and persist in soil, in water, and through direct contact with people including farmers, farm 
labourers, and abattoir workers in the environment. More research is needed on these 
transmission routes. 
 It is important for Codex Guidelines for Integrated Monitoring and Surveillance of 
Foodborne Antimicrobial Resistance, into which the FSA is crucially feeding at the time of 
writing, to incorporate pathways of AMR relating to environmental reservoirs and 
pathways of AMR in processed and internationally-sourced foods. These pathways are 
structured by the architectures of the global food system, coordinated in part by retailers 
and processors. Social science research on the geographies of the food system and the 
roles of commerce, including retail, in shaping them need to be coupled with 
microbiological research and epidemiology on AMR transmission to build the most 
effective ways of implementing antimicrobial stewardship at an international scale. 
  
                                                          
11
 http://www.europarl.europa.eu/news/en/press-room/20181018IPR16526/meps-back-plans-to-halt-spread-of-drug-
resistance-from-animals-to-humans (accessed 14/11/18). 
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8. Acronyms 
ACMSF - Advisory Committee on the Microbiological Safety of Food 
AHDB – Agriculture and Horticulture Development Board 
ABU – Antibiotic use 
AMR - antimicrobial resistance  
BPC- British Poultry Council  
BRC – British Retail Consortium 
CAP – Common Agricultural Policy 
CIAs- Critically Important Antibiotics  
CCIR – Collectiona nd Communication of Inspection Results 
DEFRA - Department for Environment, Food and Rural Affairs  
eMB – Electronic Medicines Book 
EFSA- European Food Safety Authority 
EPSRC – Engineering and physical sciences research council  
ESRC – Economic and Social Research Council 
FSA – Food Standards Agency 
LGT – Lateral Gene Transfer 
HACCP - Hazard Analysis and Critical Control Points 
NAMRIP – Network for anti-microbial resistance and infection prevention 
NPA – National Pig Association 
POST - Parliamentary Office of Science and Technology 
RFID – Radio-freduency identification 
RUMA - The Responsible use of Medicines in Agriculture Alliance  
 (UK)VARSS-Veterinary Antimicrobial Resistance and Sales Surveillance  
UKRI – United Kingdom Research Innovation 
UN – United Nations 
VMD – Veterinary Medicine Directorate  
 
 
